ZA200804896B - Azithromycin for treatment of granulomatous rosacea - Google Patents
Azithromycin for treatment of granulomatous rosaceaInfo
- Publication number
- ZA200804896B ZA200804896B ZA200804896A ZA200804896A ZA200804896B ZA 200804896 B ZA200804896 B ZA 200804896B ZA 200804896 A ZA200804896 A ZA 200804896A ZA 200804896 A ZA200804896 A ZA 200804896A ZA 200804896 B ZA200804896 B ZA 200804896B
- Authority
- ZA
- South Africa
- Prior art keywords
- azithromycin
- treatment
- granulomatous rosacea
- granulomatous
- rosacea
- Prior art date
Links
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 title 1
- 229960004099 azithromycin Drugs 0.000 title 1
- 201000004700 rosacea Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73484305P | 2005-11-09 | 2005-11-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200804896B true ZA200804896B (en) | 2009-07-29 |
Family
ID=38309684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200804896A ZA200804896B (en) | 2005-11-09 | 2008-06-05 | Azithromycin for treatment of granulomatous rosacea |
Country Status (10)
Country | Link |
---|---|
US (1) | US20070105788A1 (xx) |
EP (1) | EP1945227A4 (xx) |
JP (1) | JP2009514963A (xx) |
CN (1) | CN101304750A (xx) |
AU (1) | AU2006336612A1 (xx) |
BR (1) | BRPI0617693A2 (xx) |
CA (1) | CA2626551A1 (xx) |
RU (1) | RU2008122964A (xx) |
WO (1) | WO2007086978A2 (xx) |
ZA (1) | ZA200804896B (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8124123B2 (en) * | 2007-09-05 | 2012-02-28 | Dow Pharmaceutical Sciences, Inc. | Controlled release azithromycin solid dosages forms |
US8143227B2 (en) * | 2007-09-05 | 2012-03-27 | Dow Pharmaceutical Sciences, Inc. | Azithromycin for treatment of skin disorders |
JP5547096B2 (ja) * | 2008-02-28 | 2014-07-09 | アール.ピー. シェーラー テクノロジーズ エルエルシー | 多型を最小化する方法 |
MX2011000247A (es) * | 2008-07-10 | 2011-03-30 | Inspire Pharmaceuticals Inc | Composicion farmaceutica para el tratamiento de blefaritis. |
US20100190734A1 (en) * | 2009-01-23 | 2010-07-29 | Romulus Kimbro Brazzell | Method of treating dry eye disease with azithromycin |
WO2012092378A1 (en) * | 2010-12-29 | 2012-07-05 | Inspire Pharmaceuticals, Inc. | Method for treating blepharitis |
CN107823123A (zh) | 2011-06-28 | 2018-03-23 | 化学研究有限公司 | 高剂量粘膜粘附甲硝唑水基凝胶制剂及其治疗细菌性阴道病的用途 |
US20140206735A1 (en) * | 2012-12-20 | 2014-07-24 | Medicis Pharmaceutical Corporation | High dosage topical metronidazole aqueous-based gel formulations and their use to treat rosacea |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002089743A2 (en) * | 2001-05-09 | 2002-11-14 | The Regents Of The University Of Michigan | Use of compositions for treating rosacea |
-
2006
- 2006-11-08 CA CA002626551A patent/CA2626551A1/en not_active Abandoned
- 2006-11-08 US US11/594,451 patent/US20070105788A1/en not_active Abandoned
- 2006-11-08 AU AU2006336612A patent/AU2006336612A1/en not_active Abandoned
- 2006-11-08 CN CNA2006800418105A patent/CN101304750A/zh active Pending
- 2006-11-08 BR BRPI0617693-3A patent/BRPI0617693A2/pt not_active IP Right Cessation
- 2006-11-08 WO PCT/US2006/043339 patent/WO2007086978A2/en active Application Filing
- 2006-11-08 EP EP06849873A patent/EP1945227A4/en not_active Withdrawn
- 2006-11-08 JP JP2008540128A patent/JP2009514963A/ja active Pending
- 2006-11-08 RU RU2008122964/14A patent/RU2008122964A/ru not_active Application Discontinuation
-
2008
- 2008-06-05 ZA ZA200804896A patent/ZA200804896B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JP2009514963A (ja) | 2009-04-09 |
EP1945227A2 (en) | 2008-07-23 |
BRPI0617693A2 (pt) | 2011-08-02 |
CA2626551A1 (en) | 2007-08-02 |
RU2008122964A (ru) | 2009-12-20 |
EP1945227A4 (en) | 2009-09-30 |
CN101304750A (zh) | 2008-11-12 |
WO2007086978A2 (en) | 2007-08-02 |
US20070105788A1 (en) | 2007-05-10 |
AU2006336612A1 (en) | 2007-08-02 |
WO2007086978A3 (en) | 2007-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1982660A4 (en) | TREATMENT ENDOSCOPE | |
ZA200800907B (en) | Treatment of cancer | |
IL197137A0 (en) | Tonsillitis treatment | |
IL197315A0 (en) | Treatment of cancer | |
SI1960370T1 (sl) | Derivati piridiazinona za zdravljenje tumorjev | |
EP2022433A4 (en) | ENDOSCOPE TREATMENT SYSTEM | |
GB0624874D0 (en) | Treatment | |
ZA200804896B (en) | Azithromycin for treatment of granulomatous rosacea | |
GB0600692D0 (en) | Well treatment | |
EP2057953A4 (en) | TREATMENT TOOL FOR AN ENDOSCOPE | |
IL198692A0 (en) | Methods for treating pompe disease | |
GB0718523D0 (en) | Agricultural treatment | |
GB0513096D0 (en) | Treatment of microbial infections | |
EP2088862A4 (en) | METHOD OF TREATING CANCER | |
GB0520067D0 (en) | Treatment of cancer | |
IL226362A0 (en) | compounds, and methods for treating cancer | |
HK1225304A1 (zh) | 治療骨癌 | |
ZA200708423B (en) | Use of macrolides for treating intestinal inflammation | |
GB0604460D0 (en) | Treatment | |
GB0623740D0 (en) | Treatment of disease | |
GB0507685D0 (en) | Cancer treatment | |
GB0710871D0 (en) | Cancer treatment | |
GB0624439D0 (en) | Technique for treatment of gall-and kidney-stones | |
GB0600903D0 (en) | Treatment of cancer | |
GB0604741D0 (en) | Cancer Treatment |